| LONZA N | 587,40 / -0,03% |
| 日期/时间 | 15.01. / 17:31 |
| 涨跌。 / 涨跌。(%) | -0,20 / -0,03% |
| Bid | - / 70 |
| Ask | 590,00 / 20 |
| 打开 | 587,20 |
| 以往收市 | 587,60 |
| 高 | 589,00 |
| 低 | 581,40 |
| 成交量 [CHF] | 163.529.875,20 |
| 成交量 [Units] | 279.020 |
| Price fixings | 7086 |
| ISIN | CH0013841017 |
| 符号 | LONN |
| 交易所 | SIX Swiss Exchange |
| 类型 | 股票 |
所有交易
| 交易所 | 最后的 | 成交量 | |
|---|---|---|---|
| Lang & Schwa.. | 541,600 |  |
|
| SIX Swiss Ex.. | 587,40 | |
279.020 |
| London Inter.. | 587,40 | |
33.699 |
| Nasdaq Other.. | 663,0400 | |
103 |
| Mexico | 13.159,94 |  |
270 |
| Cboe Europe .. | 328,30 | 47.868 | |
| Turquoise | 328,30 | |
18.782 |
| Cboe Europe .. | 328,00 | 12.923 | |
| TradeGate | 294,000 | 298 | |
| Frankfurt | 293,9000 | 63 | |
| Düsseldorf | 291,20 | 0 | |
| München | 291,30 | 0 | |
| Berlin | 296,90 | 0 | |
| Hamburg | 291,30 | 0 | |
| gettex | 296,100 | ||
| Singapore | 79,97 | 500 | |
| EUREX | Options | ||
新闻
- Capricor Collaborates with Lonza for the Development of CAP-1002, its Cell Therapy Candidate for the Treatment of Duchenne Muscular Dystrophy and Other Indications
12.01.2021 / 15:05 - GlobeNewswire - Achilles Therapeutics Appoints Arjan Roozen as VP, Site Head and General Manager
08.01.2021 / 13:00 - GlobeNewswire - Arbor Biotechnologies and Lonza Enter into Gene Editing Technology Licensing Deal
23.12.2020 / 14:00 - GlobeNewswire - Recro Announces Executive Changes
16.12.2020 / 13:00 - GlobeNewswire - Avid Bioservices Announces Appointment of Jeanne Thoma to Board of Directors
07.12.2020 / 22:05 - GlobeNewswire